BRCA2 and breast carcinoma: As a confirmation of this, patients from South Sardinia (the geographical area with the preponderance of BRCA1 mutations) presented a significantly higher TNBC frequency compared with that in breast cancer cases from Middle-North Sardinia (the area with prevalent BRCA2 mutations); ~12 vs. 4%, respectively (P=0.037).